A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby‐Arnon, Charles H. Yoon, Tabea Moll et al.|Cell|2018Cited by 1.5k
The neuropeptide NMU amplifies ILC2-driven allergic lung inflammationAntonia Wallrapp, Vijay K. Kuchroo, Samantha J. Riesenfeld et al.|Nature|2017Cited by 633
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Eliezer M. Van Allen, Meng Xiao He et al.|Cancer Cell|2021Cited by 624
A single-cell landscape of high-grade serous ovarian cancerBenjamin Izar, Aviv Regev, Itay Tirosh et al.|Nature Medicine|2020Cited by 522
Cycling cancer persister cells arise from lineages with distinct programsYaara Oren, Aviv Regev, Michael Tsabar et al.|Nature|2021Cited by 514